HOME >> MEDICINE >> NEWS
Long-term aspirin use associated with reduced risk of dying in women

Women who take low to moderate doses of aspirin have a reduced risk of death from any cause, and especially heart diseaserelated deaths, according to a report in the March 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Some studies have provided evidence that aspirin may reduce the risk of heart disease and some types of cancer, the two leading causes of death in U.S. women, according to background information in the article. However, it is unclear whether aspirin reduces the risk of death overall for women.

Andrew T. Chan, M.D., M.P.H., Massachusetts General Hospital and Harvard Medical School, Boston, and colleagues examined the association between aspirin use and death in 79,439 women enrolled in the Nurses Health Study, a large group of female nurses who have been followed since 1976. Beginning in 1980 and again every two years through 2004, the women were asked if they used aspirin regularly and if so, how many tablets they typically took per week. At the beginning of the study, the women had no history of cardiovascular disease or cancer.

A total of 45,305 women did not use aspirin; 29,132 took low to moderate doses (one to 14 standard 325-milligram tablets of aspirin per week); and 5,002 took more than 14 tablets per week. By June 1, 2004, 9,477 of the women had died, 1,991 of heart disease and 4,469 of cancer. Women who reported using aspirin currently had a 25 percent lower risk of death from any cause than women who never used aspirin regularly. The association was stronger for death from cardiovascular disease (women who used aspirin had a 38 percent lower risk) than for death from cancer (women who used aspirin had a 12 percent lower risk).

"Use of aspirin for one to five years was associated with significant reductions in cardiovascular mortality," the authors write. "In contrast, a significant reduction in risk of cancer deaths was not observed until after 10 years of as
'"/>

Contact: Sue McGreevey
617-724-2764
JAMA and Archives Journals
26-Mar-2007


Page: 1 2 3

Related medicine news :

1. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
2. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
3. Long-term data on safety and effectiveness of antiobesity drugs needed
4. Long-term financial costs associated with prostate cancer treatment
5. Long-term effects of non-alcoholic fatty liver disease
6. Long-term outcomes for prostate cancer show IMRT Curative: 89 percent disease-free 8 years later
7. Long-term abstinence may resolve many of the neurocognitive deficits associated with alcoholism
8. Long-term safety results released for breast cancer drugs
9. Long-term ibuprofen regimen after brain injury worsens cognition in animal study
10. Media availability: Long-term survival of heart attack patients with shock
11. Long-term estrogen therapy linked to breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/11/2019)... ... 2019 , ... PracticeLink Live! Atlanta Physician Career Fair will take place Thursday, ... p.m. and continue until 8:00 p.m. A free, optional seminar for job-seeking physicians, residents ... p.m. , Both the career fair and seminar are open to residents and fellows, ...
(Date:11/9/2019)... ... November 09, 2019 , ... On Monday, DOROT was featured in ... and disabled 64-year-old New Yorker who recently faced homelessness. A call to 311 eventually ... until she found a new home in an assisted-living facility in Brooklyn. , DOROT ...
(Date:11/7/2019)... SAN FRANCISCO (PRWEB) , ... November 07, 2019 , ... ... available in select southern markets. The product line includes a 4 and a 7 ... that [can] transmit diseases, such as Zika, West Nile Virus and Encephalitis, without exposing ...
(Date:11/6/2019)... ... November 06, 2019 , ... ... label nutritional bar and functional powder solutions, recently achieved FSSC 22000 Certification of ... “We are pleased to share the news that we have achieved FSSC 22000 ...
(Date:11/6/2019)... ... 06, 2019 , ... Heritage Woods of Dwight is celebrating 10 years of ... to 3 p.m. on Nov. 7. , “Since the beginning, Heritage Woods of Dwight ... of Gardant Management Solutions, the company that manages the community. “With the opportunity for ...
Breaking Medicine News(10 mins):
(Date:11/11/2019)... , ... November 11, 2019 , ... ... participation in Corporate Compliance and Ethics Week. The Society of Corporate Compliance ... event, which was scheduled this year from November 3 through 9, 2019. This ...
(Date:11/11/2019)... ST. PETERS, Mo. (PRWEB) , ... November 11, ... ... in an extensive range of orthopedic procedures, Dr. R. Keith Jarman adds a ... Missouri. , As a general orthopedist with 30 years of experience, Dr. Jarman ...
(Date:11/11/2019)... ... November 11, 2019 , ... ... and have a major impact in the oncology field. While these approaches ... be overcome. Among these, defining valuable and adapted combination protocols, predicting responders ...
Breaking Medicine Technology:
Cached News: